Viewing data from:

BUMETANIDE

ANDA

BUMETANIDE | A212019 | RISING PHARMA HOLDINGS INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: BUMEX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 3 NDCs

Highest NADAC/Unit

$0.1855

per ea

Lowest NADAC/Unit

$0.1114

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
16571067701BUMETANIDE 2 MG TABLET	$0.1855	EA	Generic	—	2026-10-21
16571067901BUMETANIDE 0.5 MG TABLET	$0.1331	EA	Generic	—	2026-10-21
16571067801BUMETANIDE 1 MG TABLET	$0.1114	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain8 active DMFs2 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

GUILIN PHARMACEUTICAL CO LTDBUMETANIDE USP

DMF 86821990

OLON SPABUMETANIDE

DMF 109941994

MEDILUX LABORATORIES PVT LTDBUMETANIDE USP

DMF 418302025

INDUSTRIALE CHIMICA SRLBUMETANIDE

DMF 247502011

UNICHEM LABORATORIES LTDBUMETANIDE USP

DMF 420472025

SOLARA ACTIVE PHARMA SCIENCES LTDBUMETANIDE USP

DMF 332612018

MSN LABORATORIES PRIVATE LTDBUMETANIDE USP

DMF 339152019

HAINAN POLY PHARM CO LTDBUMETANIDE USP

DMF 402722024

QUIMICA SINTETICA SAInactiveBUMETANIDE

DMF 84351990

LEO PHARMACEUTICAL PRODUCTS LTDInactiveBUMETANIDE PURE MICRONISED

DMF 127021997

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 0.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 12, 2019

No patent or exclusivity listings for this strength.

#002 — 1MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 12, 2019

#003 — 2MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 12, 2019